• 11/10/2024

Shanghai Henlius Biotech shares soar in Hong Kong after Fosun’s US$690 million buyout offer

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Henlius joins a wave of companies that have left Hong Kong’s stock market this year, either through privatisation or voluntary delisting having found themselves undervalued.

https://www.scmp.com/business/markets/article/3267920/shanghai-henlius-biotech-shares-soar-hong-kong-after-fosuns-us690-million-buyout-offer?utm_source=rss_feed